Cat. No. | Product Name / Activity |
---|---|
6253 | F 127 (20% solution in DMSO) |
Nonionic detergent | |
0523 | 4F 4PP oxalate |
Selective 5-HT2A antagonist | |
3414 | FAK Inhibitor 14 |
Selective FAK inhibitor | |
7287 | FAM-DEALA-Hyp-YIPD |
Fluorescent HIF-1α peptide; can be used to evaluate the effect of VHL binding on degradation activity | |
7452 | FAM-DEALAHypYIPMDDDFQLRSF |
Fluorescent HIF-1α peptide; can be used to evaluate the effect of VHL binding on degradation activity | |
7306 | FC 11 |
Highly potent focal adhesion kinase (FAK) Degrader (PROTAC®) | |
0453 | FCCP |
Oxidative phosphorylation uncoupler | |
5200 | FFN 102 mesylate |
Selective fluorescent substrate of DAT and VMAT2 | |
5911 | FFN 200 dihydrochloride |
Selective fluorescent VMAT2 substrate | |
5043 | FFN 206 dihydrochloride |
Fluorescent VMAT2 substrate | |
6717 | FFN 270 |
Fluorescent substrate for NET and VMAT2 | |
3878 | FFN 511 |
Fluorescent substrate for VMAT2 | |
0554 | FG 7142 |
Benzodiazepine inverse agonist | |
0658 | FGIN-1-27 |
Potent, specific ligand for mitochondrial DBI receptor | |
5254 | FH 1 |
Enhances iPSC-derived hepatocyte differentiation and maturation | |
4344 | FH 535 |
Inhibitor of Wnt/β-catenin signaling | |
7644 | FHT 1015 |
Potent and selective SMARCA4/2 inhibitor | |
7645 | FHT 2344 |
Potent SMARCA2/4 inhibitor | |
5304 | FICZ |
High affinity aryl hydrocarbon receptor (AhR) agonist | |
4002 | FIIN 1 hydrochloride |
Potent, irreversible FGFR inhibitor | |
6280 | FIN 56 |
Ferroptosis activator | |
3600 | FIPI |
Phospholipase D inhibitor | |
5440 | FITC |
Green fluorescent dye | |
7627 | FITC-labelled Keap1-Nrf2 probe |
Fluorescent Keap1-Nrf2 peptide | |
6859 | FITM |
Potent and selective negative allosteric modulator of mGlu1 receptors | |
3515 | FK 228 |
Potent and selective class I histone deacetylase inhibitor; antitumor | |
3631 | FK 506 |
Potent calcineurin inhibitor; immunosuppressant | |
8072 | FK 866 New |
Potent and non-competitive NAMPT inhibitor; induces apoptosis and autophagy | |
2400 | FK 888 |
High affinity NK1 antagonist | |
6653 | FM19G11 |
HIF α-subunit inhibitor | |
7158 | FMF-04-159-2 |
Potent covalent CDK14 and CDK16 inhibitor; also inhibits other TAIRE kinase family members | |
7159 | FMF-04-159-R |
Potent CDK14 and CDK16 inhibitor; displays reversible inhibition of CDK14 | |
7373 | FNIR-Tag, NHS |
Near-infrared fluorescent dye for labeling of amines; supplied as NHS ester | |
2926 | FPA 124 |
Akt/PKB inhibitor | |
1403 | FPL 64176 |
Potent CaV1.x activator | |
6237 | FPS ZM1 |
High affinity antagonist of RAGE | |
1507 | FR 122047 hydrochloride |
Cyclooxygenase (COX-1) inhibitor | |
3643 | FR 171113 |
PAR1 antagonist | |
3706 | FR 180204 |
Selective ERK inhibitor | |
5190 | FRAX 486 |
Potent PAK inhibitor; brain penetrant and orally bioavailable | |
6029 | FRAX 597 |
Potent group I PAK inhibitor | |
4751 | FSLLRY-NH2 |
PAR2 peptide antagonist | |
6784 | FTBMT |
Potent and selective GPR52 agonist; orally bioavailable and BBB permeable | |
5000 | FTIDC |
Potent and selective negative allosteric modulator of mGlu1 receptors; also mGlu1 inverse agonist | |
6176 | FTY 720 |
Potent S1P receptor agonist; also immunosuppressant | |
2220 | FURA-2AM |
Fluorescent Ca2+ indicator | |
6323 | FX 1 |
Bcl-6 inhibitor; 10-fold more potent than endogenous Bcl-6 corepressors | |
7290 | Famotidine |
Potent and high affinity H2 biased inverse agonist | |
6100 | Fasentin |
GLUT1/GLUT4 inhibitor; also Fas-sensitizer | |
0541 | Fasudil hydrochloride |
Inhibitor of cyclic nucleotide dependent- and Rho-kinases | |
4444 | Fatostatin A |
Cell permeable inhibitor of SREBP activation | |
7225 | Favipiravir |
Viral RNA polymerase inhibitor | |
4427 | Febuxostat |
Xanthine oxidase inhibitor | |
6407 | Fendiline Hydrochloride |
Inhibits KRas localization to the plasma membrane; also L-type calcium channel blocker | |
2386 | Fenobam |
Potent and selective mGlu5 negative allosteric modulator (NAM) | |
4113 | Fenofibrate |
PPARα agonist | |
1659 | Fenoldopam hydrochloride |
Selective D1-like partial agonist | |
6926 | Fenoprofen calcium |
Positive allosteric modulator of MC3 receptors; exhibits biased signaling | |
1396 | Fenretinide |
Synthetic retinoid; antiproliferative and antioxidant | |
5180 | Ferrostatin 1 |
Selective inhibitor of erastin induced ferroptosis | |
2563 | Fexaramine |
Potent, selective farnesoid X receptor (FXR) agonist | |
6250 | Filipin III |
Fluorescent cholesterol stain; also polyene antibiotic | |
3293 | Finasteride |
Type II 5α-reductase inhibitor | |
5016 | Fisetin |
Naturally occuring flavonoid and antioxidant; neuroprotective | |
3094 | Flavopiridol hydrochloride |
Cdk inhibitor; potently inhibits cdk2 and cdk9 | |
1470 | Flecainide acetate |
Cardiac Na+ channel blocker. Antiarrhythmic | |
3764 | Fluconazole |
Triazole antifungal agent | |
3495 | Fludarabine |
Purine analog; inhibits DNA synthesis | |
4522 | Flufenamic acid |
Calcium-activated chloride channel blocker; NSAID. Also activates TRPC6 | |
1328 | Flumazenil |
Benzodiazepine antagonist | |
6255 | Fluo-4 AM |
Cell-permeable, fluorescent Ca2+ indicator | |
6456 | Fluorescein Tyramide |
Green fluorescent reagent widely used for signal amplification in IHC and FISH | |
6574 | Fluorescein-NAD+ |
Fluorescent NAD+; substrate for ADP-ribosylation for use in PARP assays | |
3257 | 5-Fluorouracil |
Thymidylate synthetase inhibitor | |
0927 | Fluoxetine hydrochloride |
5-HT reuptake inhibitor | |
4057 | Flupenthixol dihydrochloride |
Dopamine antagonist | |
2867 | Flupirtine maleate |
KV7 channel activator; also GABAA modulator and indirect NMDA antagonist | |
0478 | Flurofamide |
Urease inhibitor | |
4094 | Flutamide |
Non-steroidal androgen receptor antagonist | |
2226 | Flutax 1 |
Fluorescent taxol derivative; microtubule stain | |
6254 | Flutax 2 |
Green fluorescent taxol derivative; binds microtubules | |
2007 | Fluticasone propionate |
Selective high affinity glucocorticoid receptor agonist | |
3309 | Fluvastatin sodium |
Potent HMG-CoA reductase inhibitor | |
1033 | Fluvoxamine maleate |
5-HT reuptake inhibitor | |
4690 | Fmk |
Irreversible ribosomal S6 kinase 1/2 inhibitor | |
1448 | Formoterol hemifumarate |
Potent and selective β2 agonist | |
1921 | N-Formyl-Met-Leu-Phe |
Endogenous FPR1 agonist | |
1099 | Forskolin |
Adenylyl cyclase activator | |
TB1099-RMU | Forskolin |
Forskolin synthesized to Ancillary Material Grade | |
1840 | Fostriecin sodium salt |
Potent PP2A and PP4 inhibitor | |
5461 | Foxy 5 |
Wnt5a peptide mimetic | |
2876 | Fumitremorgin C |
Inhibitor of BCRP-mediated multidrug resistance | |
3103 | Fumonisin B1 |
Inhibitor of sphingosine N-acyltransferase | |
0926 | β-Funaltrexamine hydrochloride |
Irreversible and selective μ antagonist | |
5202 | Furamidine dihydrochloride |
Selective PRMT1 inhibitor | |
3109 | Furosemide |
Na+/2Cl-/K+ (NKCC) symporter inhibitor; also GABAA antagonist | |
3015 | 2-Furoyl-LIGRLO-amide |
Potent and selective PAR2 agonist | |
6961 | FzM1.8 |
Frizzled 4 allosteric agonist; exhibits biased signaling; preserves stemness |